Teladoc Health (NYSE:TDOC) PT Lowered to $15.00

Teladoc Health (NYSE:TDOC) had its target price trimmed by Wells Fargo & Company from $17.00 to $15.00 in a research report sent to investors on Monday morning, Benzinga reports. The brokerage currently has an equal weight rating on the health services provider’s stock.

Several other brokerages also recently commented on TDOC. Truist Financial cut their price objective on shares of Teladoc Health from $23.00 to $17.00 and set a hold rating on the stock in a research report on Wednesday, March 6th. Stifel Nicolaus cut their price objective on shares of Teladoc Health from $21.00 to $16.00 and set a hold rating on the stock in a research report on Friday, April 26th. Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a research report on Thursday, February 29th. They set an overweight rating and a $22.00 price objective on the stock. Oppenheimer cut their price objective on shares of Teladoc Health from $26.00 to $21.00 and set an outperform rating on the stock in a research report on Friday, April 26th. Finally, SVB Leerink initiated coverage on shares of Teladoc Health in a research note on Monday, February 26th. They set a market perform rating and a $17.00 target price on the stock. Twelve analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of Hold and a consensus target price of $18.73.

Teladoc Health Stock Up 0.4 %

NYSE:TDOC opened at $12.81 on Monday. The firm’s 50-day moving average price is $14.54 and its 200-day moving average price is $17.63. The company has a market capitalization of $2.17 billion, a PE ratio of -8.95 and a beta of 0.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.47. Teladoc Health has a 1-year low of $12.53 and a 1-year high of $30.41.

Teladoc Health (NYSE:TDOC) last released its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The business had revenue of $646.13 million during the quarter, compared to analysts’ expectations of $637.31 million. During the same period in the prior year, the company earned ($0.37) earnings per share. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. On average, equities analysts predict that Teladoc Health will post -1.06 EPS for the current fiscal year.

Insider Transactions at Teladoc Health

In other news, CAO Richard J. Napolitano sold 3,765 shares of the stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $54,667.80. Following the transaction, the chief accounting officer now owns 18,077 shares in the company, valued at approximately $262,478.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Teladoc Health news, CTO Nikolaos P. Nanis sold 2,866 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $41,614.32. Following the sale, the chief technology officer now owns 69,850 shares in the company, valued at approximately $1,014,222. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Richard J. Napolitano sold 3,765 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $54,667.80. Following the sale, the chief accounting officer now owns 18,077 shares in the company, valued at approximately $262,478.04. The disclosure for this sale can be found here. Insiders have sold 135,441 shares of company stock worth $2,038,251 in the last quarter. Company insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. ICA Group Wealth Management LLC bought a new stake in Teladoc Health during the 4th quarter worth approximately $28,000. Hexagon Capital Partners LLC raised its stake in Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after acquiring an additional 1,065 shares during the period. RIA Advisory Group LLC bought a new stake in Teladoc Health during the 4th quarter worth approximately $36,000. GAMMA Investing LLC bought a new stake in Teladoc Health during the 4th quarter worth approximately $41,000. Finally, Principal Securities Inc. bought a new stake in Teladoc Health during the 4th quarter worth approximately $45,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.